1j34 Citations

Crystal structure of Mg2+- and Ca2+-bound Gla domain of factor IX complexed with binding protein.

J Biol Chem 278 24090-4 (2003)
Cited: 55 times
EuropePMC logo PMID: 12695512

Abstract

Factor IX is an indispensable protein required in the blood coagulation cascade. It binds to the surface of phospholipid membrane by means of a gamma-carboxyglutamic acid (Gla) domain situated at the N terminus. Recently, we showed that physiological concentrations of Mg2+ ions affect the native conformation of the Gla domain and in doing so augment the biological activity of factor IXa and binding affinity with its binding protein even in the presence of Ca2+ ions. Here we report on the crystal structures of the Mg2+/Ca2+-bound and Ca2+-bound (Mg2+-free) factor IX Gla domain (IXGD1-46) in complex with its binding protein (IX-bp) at 1.55 and 1.80 A resolutions, respectively. Three Mg2+ and five Ca2+ ions were bound in the Mg2+/Ca2+-bound IXGD1-46, and the Mg2+ ions were replaced by Ca2+ ions in Mg2+-free IXGD1-46. Comparison of Mg2+/Ca2+-bound with Ca2+-bound structures of the complexes showed that Mg2+ ion, which formed a bridge between IXGD1-46 and IX-bp, forced IXGD1-46 to rotate 4 degrees relative to IX-bp and hence might be the cause of a more tight interaction between the molecules than in the case of the Mg2+-free structure. The results clearly suggest that Mg2+ ions are required to maintain native conformation and in vivo function of factor IX Gla domain during blood coagulation.

Articles - 1j34 mentioned but not cited (2)



Reviews citing this publication (12)

  1. Anticoagulant proteins from snake venoms: structure, function and mechanism. Kini RM. Biochem J 397 377-387 (2006)
  2. Haemostatically active proteins in snake venoms. Sajevic T, Leonardi A, Križaj I. Toxicon 57 627-645 (2011)
  3. Protein complexes in snake venom. Doley R, Kini RM. Cell Mol Life Sci 66 2851-2871 (2009)
  4. Structures and functions of snake venom CLPs (C-type lectin-like proteins) with anticoagulant-, procoagulant-, and platelet-modulating activities. Morita T. Toxicon 45 1099-1114 (2005)
  5. Snake venoms and hemostasis. Lu Q, Clemetson JM, Clemetson KJ. J Thromb Haemost 3 1791-1799 (2005)
  6. The blood coagulation cascade. Schenone M, Furie BC, Furie B. Curr Opin Hematol 11 272-277 (2004)
  7. Structural biology of factor VIIa/tissue factor initiated coagulation. Vadivel K, Bajaj SP. Front Biosci (Landmark Ed) 17 2476-2494 (2012)
  8. Structure-function relationships of C-type lectin-related proteins. Morita T. Pathophysiol Haemost Thromb 34 156-159 (2005)
  9. Activation mechanisms of coagulation factor IX. Zögg T, Brandstetter H. Biol Chem 390 391-400 (2009)
  10. Potential blood clotting factors and anticoagulants. Jin NZ, Gopinath SCB. Biomed Pharmacother 84 356-365 (2016)
  11. Use of snake venom inhibitors in studies of the function and tertiary structure of coagulation factors. Morita T. Int J Hematol 79 123-129 (2004)
  12. Crystallographic studies on protein misfolding: Domain swapping and amyloid formation in the SH3 domain. Cámara-Artigas A. Arch Biochem Biophys 602 116-126 (2016)

Articles citing this publication (41)

  1. The endothelial protein C receptor supports tissue factor ternary coagulation initiation complex signaling through protease-activated receptors. Disse J, Petersen HH, Larsen KS, Persson E, Esmon N, Esmon CT, Teyton L, Petersen LC, Ruf W. J Biol Chem 286 5756-5767 (2011)
  2. Snake venomics: comparative analysis of the venom proteomes of the Tunisian snakes Cerastes cerastes, Cerastes vipera and Macrovipera lebetina. Bazaa A, Marrakchi N, El Ayeb M, Sanz L, Calvete JJ. Proteomics 5 4223-4235 (2005)
  3. Crystal structure of the calcium-stabilized human factor IX Gla domain bound to a conformation-specific anti-factor IX antibody. Huang M, Furie BC, Furie B. J Biol Chem 279 14338-14346 (2004)
  4. Peptides of pHLIP family for targeted intracellular and extracellular delivery of cargo molecules to tumors. Wyatt LC, Moshnikova A, Crawford T, Engelman DM, Andreev OA, Reshetnyak YK. Proc Natl Acad Sci U S A 115 E2811-E2818 (2018)
  5. Dynamical view of membrane binding and complex formation of human factor VIIa and tissue factor. Ohkubo YZ, Morrissey JH, Tajkhorshid E. J Thromb Haemost 8 1044-1053 (2010)
  6. Na+ site in blood coagulation factor IXa: effect on catalysis and factor VIIIa binding. Schmidt AE, Stewart JE, Mathur A, Krishnaswamy S, Bajaj SP. J Mol Biol 350 78-91 (2005)
  7. The linker connecting the two kringles plays a key role in prothrombin activation. Pozzi N, Chen Z, Pelc LA, Shropshire DB, Di Cera E. Proc Natl Acad Sci U S A 111 7630-7635 (2014)
  8. Snake-venom-derived Factor IX-binding protein specifically blocks the gamma-carboxyglutamic acid-rich-domain-mediated membrane binding of human Factors IX and X. Gopinath SC, Shikamoto Y, Mizuno H, Kumar PK. Biochem J 405 351-357 (2007)
  9. Plasma protein S contains zinc essential for efficient activated protein C-independent anticoagulant activity and binding to factor Xa, but not for efficient binding to tissue factor pathway inhibitor. Heeb MJ, Prashun D, Griffin JH, Bouma BN. FASEB J 23 2244-2253 (2009)
  10. Structural and functional studies of γ-carboxyglutamic acid domains of factor VIIa and activated Protein C: role of magnesium at physiological calcium. Vadivel K, Agah S, Messer AS, Cascio D, Bajaj MS, Krishnaswamy S, Esmon CT, Padmanabhan K, Bajaj SP. J Mol Biol 425 1961-1981 (2013)
  11. Structural determinants of factor IX(a) binding in nitrophorin 2, a lipocalin inhibitor of the intrinsic coagulation pathway. Gudderra NP, Ribeiro JM, Andersen JF. J Biol Chem 280 25022-25028 (2005)
  12. Exogenous Magnesium Chloride Reduces the Activated Partial Thromboplastin Times of Lupus Anticoagulant-Positive Patients. Tokutake T, Baba H, Shimada Y, Takeda W, Sato K, Hiroshima Y, Kirihara T, Shimizu I, Nakazawa H, Kobayashi H, Ishida F. PLoS One 11 e0157835 (2016)
  13. An RNA aptamer that discriminates bovine factor IX from human factor IX. Gopinath SC, Balasundaresan D, Akitomi J, Mizuno H. J Biochem 140 667-676 (2006)
  14. Anticoagulation factor I, a snaclec (snake C-type lectin) from Agkistrodon acutus venom binds to FIX as well as FX: Ca2+ induced binding data. Zhang Y, Xu X, Shen D, Song J, Guo M, Yan X. Toxicon 59 718-723 (2012)
  15. Letter Mg(2+) binding to the Gla domain of factor X influences the interaction with tissue factor. Persson E, Ostergaard A. J Thromb Haemost 5 1977-1978 (2007)
  16. pH-Dependent structural changes at Ca(2+)-binding sites of coagulation factor IX-binding protein. Suzuki N, Fujimoto Z, Morita T, Fukamizu A, Mizuno H. J Mol Biol 353 80-87 (2005)
  17. Letter Contribution of magnesium in binding of factor IXa to the phospholipid surface: implications for vitamin K-dependent coagulation proteins. Messer AS, Velander WH, Bajaj SP. J Thromb Haemost 7 2151-2153 (2009)
  18. Conformational comparability of factor IX-Fc fusion protein, factor IX, and purified Fc fragment in the absence and presence of calcium. Houde D, Berkowitz SA. J Pharm Sci 101 1688-1700 (2012)
  19. Letter Role of magnesium in factor XIa catalyzed activation of factor IX: calcium binding to factor IX under physiologic magnesium. Agah S, Bajaj SP. J Thromb Haemost 7 1426-1428 (2009)
  20. Structural insights into the interaction of blood coagulation co-factor VIIIa with factor IXa: a computational protein-protein docking and molecular dynamics refinement study. Venkateswarlu D. Biochem Biophys Res Commun 452 408-414 (2014)
  21. Effect of metal ion substitutions in anticoagulation factor I from the venom of Agkistrodon acutus on the binding of activated coagulation factor X and on structural stability. Xu X, Zhang L, Shen D, Wu H, Peng L, Li J. J Biol Inorg Chem 14 559-571 (2009)
  22. Metal ion binding to anticoagulation factor II from the venom of Agkistrodon acutus: stabilization of the structure and regulation of the binding affinity to activated coagulation factor X. Shen D, Xu X, Wu H, Peng L, Zhang Y, Song J, Su Q. J Biol Inorg Chem 16 523-537 (2011)
  23. Purification and characterization of Cc-Lec, C-type lactose-binding lectin: A platelet aggregation and blood-clotting inhibitor from Cerastes cerastes venom. Samah S, Fatah C, Jean-Marc B, Safia KT, Fatima LD. Int J Biol Macromol 102 336-350 (2017)
  24. Sodium-site in serine protease domain of human coagulation factor IXa: evidence from the crystal structure and molecular dynamics simulations study. Vadivel K, Schreuder HA, Liesum A, Schmidt AE, Goldsmith G, Bajaj SP. J Thromb Haemost 17 574-584 (2019)
  25. Structural analysis of factor IX protein variants to predict functional aberration causing haemophilia B. Mukherjee S, Saha A, Biswas P, Mandal C, Ray K. Haemophilia 14 1076-1081 (2008)
  26. Anticoagulant mechanism of factor IX/factor X-binding protein isolated from the venom of Trimeresurus flavoviridis. Ishikawa M, Kumashiro M, Yamazaki Y, Atoda H, Morita T. J Biochem 145 123-128 (2009)
  27. Biomolecular discrimination analyses by surface plasmon resonance. Gopinath SC, Kumar PK. Analyst 139 2678-2682 (2014)
  28. Effect of Ca2+ and Mg2+ concentration in culture medium on the activation of recombinant factor IX produced in Chinese hamster ovary cells. Kim WH, Kim JS, Yoon Y, Lee GM. J Biotechnol 142 275-278 (2009)
  29. Characterization of a monoclonal antibody B1 that recognizes phosphorylated Ser-158 in the activation peptide region of human coagulation factor IX. Atoda H, Yokota E, Morita T. J Biol Chem 281 9314-9320 (2006)
  30. Computational study of coagulation factor VIIa's affinity for phospholipid membranes. Taboureau O, Olsen OH. Eur Biophys J 36 133-144 (2007)
  31. Indirect role of Ca2+ in the assembly of extracellular matrix proteins. Diao J, Tajkhorshid E. Biophys J 95 120-127 (2008)
  32. Binding of Ca2+ and Zn2+ to factor IX/X-binding protein from venom of Agkistrodon halys Pallas: stabilization of the structure during GdnHCl-induced and thermally induced denaturation. Wu H, Xu X, Shen D, Peng L, Song J, Zhang Y. J Biol Inorg Chem 16 69-79 (2011)
  33. Ca(2+) -induced binding of anticoagulation factor II from the venom of Agkistrodon acutus with factor IX. Shen DK, Xu XL, Zhang Y, Song JJ, Yan XC, Guo MC. Biopolymers 97 818-824 (2012)
  34. Calcium binding to a factor ix Fc fusion protein and effects on higher-order structure. Li H, Bai S, Wei JY, Berkowitz SA, Brader ML. J Pharm Sci 100 4597-4606 (2011)
  35. Crystallization and preliminary X-ray analysis of coagulation factor IX-binding protein from habu snake venom at pH 6.5 and 4.6. Suzuki N, Shikamoto Y, Fujimoto Z, Morita T, Mizuno H. Acta Crystallogr Sect F Struct Biol Cryst Commun 61 147-149 (2005)
  36. Re-evaluation of M-LAO, L-amino acid oxidase, from the venom of Gloydius blomhoffi as an anticoagulant protein. Fujisawa D, Yamazaki Y, Morita T. J Biochem 146 43-49 (2009)
  37. Epitope reactions can be gauged by relative antibody discriminating specificity (RADS) values supported by deletion, substitution and cysteine bridge formation analyses: potential uses in pathogenesis studies. Falconar AK. BMC Res Notes 5 208 (2012)
  38. Insights into stabilizing interactions in the distorted domain-swapped dimer of Salmonella typhimurium survival protein. Mathiharan YK, Savithri HS, Murthy MR. Acta Crystallogr D Biol Crystallogr 71 1812-1823 (2015)
  39. Quantifying vitamin K-dependent holoprotein compaction caused by differential γ-carboxylation using high-pressure size exclusion chromatography. Vanderslice NC, Messer AS, Vadivel K, Bajaj SP, Phillips M, Fatemi M, Xu W, Velander WH. Anal Biochem 479 6-14 (2015)
  40. In vitro induction and proteomics characterisation of a uranyl-protein interaction network in bovine serum. Szyrwiel Ł, Liauchuk V, Chavatte L, Lobinski R. Metallomics 7 1604-1611 (2015)
  41. Case Reports Herd Health Troubles Potentially Related to Aluminium Grass Silage Content in Dairy Cows. Eppe J, Djebala S, Rollin F, Guyot H. Vet Sci 10 149 (2023)


Related citations provided by authors (2)

  1. Crystal structure of an anticoagulant protein in complex with the Gla domain of factor X. Mizuno H, Fujimoto Z, Atoda H, Morita T Proc. Natl. Acad. Sci. U.S.A. 98 7230-7234 (2001)
  2. Crystal structure of coagulation factor IX-binding protein from habu snake venom at 2.6 A: implication of central loop swapping based on deletion in the linker region. Mizuno H, Fujimoto Z, Koizumi M, Kano H, Atoda H, Morita T J. Mol. Biol. 289 103-112 (1999)